Clinical Trials

Search for trials
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug, Radiation, Other, Procedure
  • Participants: 10
  • Start Date: March 25, 2021
Infusion of Off-the-Shelf Ex Vivo Expanded Cryopreserved Progenitor Cells to Facilitate the Engraftment of a Single CCR5Δ32 Homozygous or Heterozygous Cord Blood Unit in Patients With HIV and Hematological Malignancies
Clinical Trial
  • Status: Recruiting
  • Participants: 1000
  • Start Date: March 28, 2019
Longitudinal Studies of Patient With FPDMM
Search for trials
Clinical Trial
  • Status: Active, not recruiting
  • Phase: N/A
  • Intervention Type: Drug, Other
  • Participants: 26
  • Start Date: October 9, 2015
A Multicenter, Open-Label, Pilot Study of Alisertib (MLN8237), a Novel Inhibitor of Aurora Kinase A, in Adult Patients With Relapsed/Refractory Acute Megakaryoblastic Leukemia or Myelofibrosis (Including Primary and Post-Essential/Post-Polycythemic Myelofibrosis)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Other, Drug
  • Participants: 174
  • Start Date: June 2011
Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes (EQol-MDS)
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 3
  • Intervention Type: Drug, Other
  • Participants: 717
  • Start Date: April 2008
A Phase III Randomized, Double-Blind Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy + Midostaurin (PKC412) (IND #101261) or Placebo in Newly Diagnosed Patients < 60 Years of Age With FLT3 Mutated Acute Myeloid Leukemia (AML)
Clinical Trial
  • Status: Active, not recruiting
  • Intervention Type: Other, Genetic
  • Participants: 600
  • Start Date: October 2006
Multidrug Resistance Protein Gene Polymorphisms in Acute Myeloid Leukemia. A CALGB Leukemia Tissue Bank Project
Clinical Trial
  • Status: Active, not recruiting
  • Intervention Type: Genetic, Other
  • Participants: 735
  • Start Date: May 2006
Molecular Genetic Studies of Acute Myeloid Leukemia (AML) With Normal Cytogenetics. A CALGB Leukemia Tissue Bank Project
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 2
  • Intervention Type: Procedure, Biological, Radiation, Drug
  • Participants: 50
  • Start Date: February 8, 2000
Autologous Bone Marrow Transplantation for Non-M3 Acute Myeloid Leukemia (AML) in First Remission in Patients </=60 Years of Age Using Busulfan/Fractionated Total Body Irradiation (FTBI) and VP16 as the Preparative Regimen
Showing 1-8 of 8